Bionovate Technologies Corp (BIIO) Research

Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body. The firm plans to distribute these advanced systems globally, marketing them to healthcare providers and wellness centers. Founded in Cham, Switzerland, in 2010, the organization previously traded under the name MJP International Ltd. before adopting Bionovate Technologies Corp. in December 2017. Since October 7, 2020, the company has operated as an affiliated entity of Human Data AG.

Market snapshot

Symbol
BIIO
Price
$0.00
Day change
0.00%
Market cap
$775.0
P/E ratio
-0.01x
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • HLK Biotech Holding Group, Inc. (AMHD)
  • Adhera Therapeutics, Inc. (ATRX)
  • BioELife Corp. (LITH)
  • Micro Imaging Technology, Inc. (MMTC)
  • Motus GI Holdings, Inc. (MOTS)
  • Ontrak, Inc. (OTRKQ)
  • Priority Aviation, Inc. (PJET)
  • Proteonomix, Inc. (PROT)

Open Bionovate Technologies Corp (BIIO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.